New York State Common Retirement Fund
ADPT icon

New York State Common Retirement Fund’s Adaptive Biotechnologies ADPT Stock Holding History

New York State Common Retirement Fund’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Buy
145,946
+9,215
+7% +$141K ﹤0.01% 1281
2026
Q1 		$1.9M Buy
136,731
+47,122
+53% +$751K ﹤0.01% 1406
2025
Q4 		$1.46M Buy
89,609
+42,351
+90% +$691K ﹤0.01% 1531
2025
Q3 		$707K Hold
47,258
– – ﹤0.01% 1813
2025
Q2 		$551K Buy
47,258
+13,300
+39% +$121K ﹤0.01% 1875
2025
Q1 		$252K Hold
33,958
– – ﹤0.01% 2137
2024
Q4 		$204K Hold
33,958
– – ﹤0.01% 2286
2024
Q3 		$174K Hold
33,958
– – ﹤0.01% 2365
2024
Q2 		$123K Buy
33,958
+81
+0.2% +$257 ﹤0.01% 2646
2024
Q1 		$109K Sell
33,877
-140
-0.4% -$542 ﹤0.01% 2702
2023
Q4 		$167K Sell
34,017
-10,379
-23% -$47.4K ﹤0.01% 2539
2023
Q3 		$242K Buy
44,396
+333
+0.8% +$2.2K ﹤0.01% 2342
2023
Q2 		$296K Sell
44,063
-12,023
-21% -$89.4K ﹤0.01% 2331
2023
Q1 		$495K Sell
56,086
-22,325
-28% -$197K ﹤0.01% 2178
2022
Q4 		$599K Sell
78,411
-51
-0.1% -$397 ﹤0.01% 2224
2022
Q3 		$559K Buy
78,462
+936
+1% +$8.81K ﹤0.01% 2281
2022
Q2 		$627K Sell
77,526
-33,710
-30% -$296K ﹤0.01% 2248
2022
Q1 		$1.54M Sell
111,236
-11,500
-9% -$181K ﹤0.01% 1880
2021
Q4 		$3.44M Hold
122,736
– – ﹤0.01% 1480
2021
Q3 		$4.17M Hold
122,736
– – ﹤0.01% 1398
2021
Q2 		$5.01M Sell
122,736
-6,008
-5% -$234K 0.01% 1337
2021
Q1 		$5.18M Sell
128,744
-82,762
-39% -$4.48M 0.01% 1265
2020
Q4 		$12.5M Sell
211,506
-9,800
-4% -$505K 0.01% 834
2020
Q3 		$10.8M Sell
221,306
-5,500
-2% -$231K 0.01% 816
2020
Q2 		$11M Buy
226,806
+85,600
+61% +$3.12M 0.01% 829
2020
Q1 		$3.92M Buy
141,206
+111,370
+373% +$3.11M 0.01% 1152
2019
Q4 		$893K Buy
29,836
+16,100
+117% +$462K ﹤0.01% 2002
2019
Q3 		$424K Buy
13,736
+13,686
+27,372% +$559K ﹤0.01% 2409
2019
Q2 		$2K Buy
+50
New +$2.21K ﹤0.01% 3232

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

New York State Common Retirement Fund's ADPT Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Adaptive Biotechnologies (ADPT) stake by 6.7% in Q2 2026, buying an estimated $141K and bringing the position to 145,946 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

New York State Common Retirement Fund first reported a position in ADPT in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.5M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • New York State Common Retirement Fund held 145,946 shares of Adaptive Biotechnologies worth $3.13M as of Q2 2026.
  • New York State Common Retirement Fund bought 9,215 Adaptive Biotechnologies shares in Q2 2026, an estimated $141K.
  • Adaptive Biotechnologies made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1281 holding.
  • New York State Common Retirement Fund first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 29 quarters since.
  • New York State Common Retirement Fund's Adaptive Biotechnologies position peaked at $12.5M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.